Citation: | Li Zhao, Gao Pengji, Gao Jie, et al. Clinical efficacy of liver transplantation for liver cirrhosis and portal hypertension[J]. Chinese Journal of Digestive Surgery, 2014, 13(9): 683-686. DOI: 10.3760/cma.j.issn.1673-9752.2014.09.004 |
Objective:To investigate the clinical efficacy of liver transplantation for liver cirrhosis and portal hypertension.
Methods:The clinical data of 181 patients with liver cirrhosis and portal hypertension who were admitted to the People′s Hospital of Peking University from January 2000 to January 2012 were retrospectively analyzed. The efficacy of liver transplantation for liver cirrhosis and portal hypertension was investigated. The indications of liver transplantation included repeated upper gastrointestinal hemorrhage, failure of medication, surgical treatment and interventional therapy, and portal hypertension combined with hepatic functional decompensation. Orthotropic liver transplantation or piggyback liver transplantation was selected according to the condition of the patients. The pressures of the portal vein were detected before and after the transplantation of the liver graft by the manometer tube. The incidence of postoperative complications was detected. Patients were followed up regularly till December 2012. The varices and rebleeding of the esophageal veins and the survival of the patients were monitored. The survival rates was calculated using the Kaplan Meier method, and the measurement data were analyzed using the t test.
Results:Of the 181 patients, 65 received orthotropic liver transplantation, and 116 received piggyback liver transplantation. The operation time, volume of blood loss and anhepatic phase were (485± 97)minutes, (4 380±1 993)mL and (56±24)minutes, respectively. T tube was placed in 157 patients. The portal vein pressure was detected in 102 patients. The portal vein pressures before and after liver transplantation were (32±11)cmH 2O (1 cmH 2O=0.098 kPa) and (21±6)cmH 2O, respectively. There was significant difference in the portal vein pressure before and after liver transplantation (t=2.412, P<0.05). Severe infection was detected in 23 patients, acute renal failure in 20 patients, severe abdominal bleeding in 6 patients, vascular complications in 5 patients and primary graft non function in 2 patients after liver transplantation. A total of 181 patients were followed up for 6 -131 months. One hundred and thirty eight patients received endoscopy or upper gastrointestinal imaging at 1 year after liver transplantation. The varices were disappeared in 112 patients and alleviated in 26 patients, with the overall alleviation rate of 85.71%(138/161). Four patients were complicated with upper gastrointestinal rebleeding within 1 year after liver transplantation, and the rebleeding rate was 3.70%(4/108). The condition of 3 patients was alleviated by haemostatics and endoscopic treatment, and 1 patient died of liver failure caused by rebleeding. The 1 month, 1 , 5 year survival rates were 86.8%, 84.9% and 77.4%, respectively. Twenty three patients died. Fifteen patients died of multi organ dysfunction syndrome, 5 died of vascular complications (2 died of hepatic artery thrombosis, 2 died of portal vein thrombosis and 1 died of anastomotic stricture of vena cava), 2 died of primary graft non function, and 1 died of respiratory complications. Conclusion Liver transplantation is an efficient method for the treatment of liver cirrhosis and portal hypertension with the advantages of low rebleeding rate and ideal efficacy of reducing portal vein pressure.
[1] | Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association. Expert consensus on the diagnosis and treatment of esophageal and gastric variceal rupture bleeding in cirrhotic portal hypertension (2025 edition)[J]. Chinese Journal of Digestive Surgery, 2025, 24(3): 271-280. DOI: 10.3760/cma.j.cn115610-20241228-00590 |
[2] | Lyu Guoyue. Progress of therapeutic proceeding of liver transplantation in hepatocellular carcinoma with portal vein tumor thrombosis[J]. Chinese Journal of Digestive Surgery, 2024, 23(2): 215-220. DOI: 10.3760/cma.j.cn115610-20231130-00223 |
[3] | Tian Mingguo, Li Baoding, Liu Feng, Fan Xiongwei, Wang Liyun, Bo Yang, Yang Yong, Wu Guangming. Application value of peri‑gastric devascularization without dissociation of esophagus for portal hypertension[J]. Chinese Journal of Digestive Surgery, 2023, 22(12): 1484-1489. DOI: 10.3760/cma.j.cn115610-20231023-00161 |
[4] | Perioperative Management Group, Chinese Society of Organ Transplantation, Chinese Medical Associa-tion, Organ Transplantation Perioperative Management Professional Committee, Chinese College of Surgeons, Chinese Medical Doctor Association, Zhang Shuijun, Guo Wenzhi. Chinese expert consensus on perioperative management of liver transplantation in patients with portopulmonary hypertension (2021 edition)[J]. Chinese Journal of Digestive Surgery, 2022, 21(1): 10-14. DOI: 10.3760/cma.j.cn115610-20220112-00029 |
[5] | Ding Ronghua, Hu Yanmei, Li Xiaoguo, Shi Chao, Ruan Jigang, Hu Jianping, Xuan Jie, Li Yang, Wang Ping, Qi Yuzhen, Peng Fang, Qi Hailong, Yang Wei, Shen Qian, Ku Shuiping, Shi Ruichun, Wei Xuejuan, Zhang Yanping, Ding Yulin, Zhang Peifang, Hou Zhanbin, Zhang Xiaojuan, Tian Yuanlan, Wang Guizhen, Zhang Ping, Qi Yanxia, Wang Tianneng, Li Ying, Kang Ning, Xu Dan, He Ruiling, Liu Chuan, Hu Shengjuan, Bo Yang, Qi Xiaolong, Hypertension Alliance Ningxia Portal, CHESS Ningxia Collaborative Group. Current status of prevention and treatment of esophagogastric variceal bleeding in cirrhotic portal hypertension patients in Ningxia region: a multicenter study[J]. Chinese Journal of Digestive Surgery, 2021, 20(10): 1078-1084. DOI: 10.3760/cma.j.cn115610-20210928-00464 |
[6] | Chinese Society of Spleen and Portal Hypertension Surgery, Chinese Society of Surgery, Chinese Medical Association. Expert consensus on diagnosis and treatment of esophagogastric variceal bleeding in cirrhotic portal hypertension (2019 edition)[J]. Chinese Journal of Digestive Surgery, 2019, 18(12): 1087-1093. |
[7] | Chen Quan, Zhang Yu, Yue Zhendong, Fan Zhenhua, Zhao Hongwei, Wang Lei, He Fuliang, Liu Fuquan.. Clinical efficacy of transjugular intrahepatic portosystemic shunting for recurrent portal hypertension after liver transplantation[J]. Chinese Journal of Digestive Surgery, 2018, 17(10): 1013-1017. DOI: 10.3760/cma.j.issn.1673-9752.2018.10.009 |
[8] | Xu Xiao, Guo Haijun, Li Wangyao.. Treatment options for portal hypertension in the era of liver transplantation[J]. Chinese Journal of Digestive Surgery, 2018, 17(10): 992-996. DOI: 10.3760/cma.j.issn.1673-9752.2018.10.005 |
[9] | Huo Feng, Chen Jianxiong, Zheng Yujian, Tan Xiaoyu.. Effects, status and problems of liver transplantation in the treatment of portal hypertension[J]. Chinese Journal of Digestive Surgery, 2018, 17(10): 976-980. DOI: 10.3760/cma.j.issn.1673-9752.2018.10.002 |
[10] | Experts Group from the Ministry of Health Special Fund for Research in the Public Interest. Expert consensus on technical specifications of treatment of portal hypertension with esophagogastric variceal bleeding (2013 edition)[J]. Chinese Journal of Digestive Surgery, 2014, 13(6): 401-404. DOI: 10.3760/cma.j.issn.1673-9752.2014.06.001 |